Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?

Na minha lista:
Detalhes bibliográficos
Publicado no:RMD Open
Main Authors: Blokland, Sofie L M, Hillen, Maarten R, Wichers, Catharina G K, Zimmermann, Maili, Kruize, Aike A, Radstake, Timothy R D J, Broen, Jasper C A, van Roon, Joel A G
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Sjögren Syndrome
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6340518/
https://ncbi.nlm.nih.gov/pubmed/30713717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2018-000701
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados